USD $1.00-10.00 / Kilogram
USD $1.00-10.00 / Kilogram
USD $2.00-10.00 / Kilogram
USD $1.00-10.00 / Kilogram
USD $1.00-10.00 / Kilogram
repaglinide basic information |
product name: | repaglinide |
synonyms: | ag-ee-623;2-ethoxy-4-[2-[(1s)-3-methyl-1-[2-(1-piperidinyl)butyl]amino]-2-oxoethyl]-benzoic acid;repaglinide;(s)-2-ethoxy-4-(2-(3-methyl-1-(2-(piperidin-1-yl)phenyl)butylamino)-2-oxoethyl)benzoic acid;(s)-(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid;novonorm;prandin;ag-ee388zw |
cas: | 135062-02-1 |
mf: | c27h36n2o4 |
mw: | 452.59 |
einecs: | |
product categories: | pharmaceutical material and intermeidates;active pharmaceutical ingredients;chiral reagents;amino acids 13c, 2h, 15n;chemical impurities;impurities;intermediates & fine chemicals;pharmaceuticals;amino acids & derivatives;aromatics;heterocycles;api;pharmaceutical raw material;dtic-dome |
mol file: | 135062-02-1.mol |
repaglinide chemical properties |
mp | 129-130.2 °c |
storage temp. | 2-8°c |
solubility | dmso: 34 mg/ml |
form | solid |
color | white |
cas database reference | 135062-02-1(cas database reference) |
safety information |
wgk germany | 2 |
rtecs | 000000033825 |
msds information |
provider | language |
---|---|
novonorm | english |
sigmaaldrich | english |
repaglinide usage and synthesis |
chemical properties | white to off-white solid |
usage | non-sulfonylurea oral hypoglycemic agent. used as an antidiabetic |
usage | the r-enantiomer showed only weak hypoglycemic activity. repaglinide impurity |
usage | antineoplastic |
usage | a kir6 (katp) channel blocker |
biological activity | k atp channel blocker that binds with high affinity for sur1 when co-expressed with kir6.2 (k d = 0.42 nm). antidiabetic glucose regulator with hypoglycaemic effect in vivo . |
repaglinide basic information |
product name: | repaglinide |
synonyms: | ag-ee-623;2-ethoxy-4-[2-[(1s)-3-methyl-1-[2-(1-piperidinyl)butyl]amino]-2-oxoethyl]-benzoic acid;repaglinide;(s)-2-ethoxy-4-(2-(3-methyl-1-(2-(piperidin-1-yl)phenyl)butylamino)-2-oxoethyl)benzoic acid;(s)-(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid;novonorm;prandin;ag-ee388zw |
cas: | 135062-02-1 |
mf: | c27h36n2o4 |
mw: | 452.59 |
einecs: | |
product categories: | pharmaceutical material and intermeidates;active pharmaceutical ingredients;chiral reagents;amino acids 13c, 2h, 15n;chemical impurities;impurities;intermediates & fine chemicals;pharmaceuticals;amino acids & derivatives;aromatics;heterocycles;api;pharmaceutical raw material;dtic-dome |
mol file: | 135062-02-1.mol |
repaglinide chemical properties |
mp | 129-130.2 °c |
storage temp. | 2-8°c |
solubility | dmso: 34 mg/ml |
form | solid |
color | white |
cas database reference | 135062-02-1(cas database reference) |
safety information |
wgk germany | 2 |
rtecs | 000000033825 |
msds information |
provider | language |
---|---|
novonorm | english |
sigmaaldrich | english |
repaglinide usage and synthesis |
chemical properties | white to off-white solid |
usage | non-sulfonylurea oral hypoglycemic agent. used as an antidiabetic |
usage | the r-enantiomer showed only weak hypoglycemic activity. repaglinide impurity |
usage | antineoplastic |
usage | a kir6 (katp) channel blocker |
biological activity | k atp channel blocker that binds with high affinity for sur1 when co-expressed with kir6.2 (k d = 0.42 nm). antidiabetic glucose regulator with hypoglycaemic effect in vivo . |